Top Markets
Coin of the day
Awakn Life Sciences Corp. Awakn Life Sciences Corp.

Awakn Life Sciences Corp.

AWKN
Rank in Stocks #37130
Awakn Life Sciences Corp., a biotechnology firm headquartered in Toronto,... Awakn Life Sciences Corp., a biotechnology firm headquartered in Toronto, Canada, specializes in the discovery, development, and provision of psychedelic therapies. Its mission is to address addiction and other mental health challenges throughout the United Kingdom and across Europe.
Share Price
$0.07726075
Last synced: 2024-12-13
Market Cap
$1.99M
Change (1 day)
5.27%
Change (1 year)
0.00%
Country
CA
Trade Awakn Life Sciences Corp. (AWKN)

Category

P/E ratio for Awakn Life Sciences Corp. (AWKN)
P/E ratio as of 2026 TTM: 0
According to Awakn Life Sciences Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Awakn Life Sciences Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
29.20 -
US
30.62 -
NL
- -
CH
- -
KR
18.38 -
BE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.